Sumatriptan and Thinking abnormal - a phase IV clinical study of FDA data

Summary:

Thinking abnormal is reported as a side effect among people who take Sumatriptan (sumatriptan succinate), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Relpax, and have Headache.

The phase IV clinical study analyzes which people have Thinking abnormal when taking Sumatriptan. It is created by eHealthMe based on reports of 17,179 people who have side effects when taking Sumatriptan from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,157 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Thinking abnormal?

Thinking abnormal is found to be associated with 1,147 drugs and 1,176 conditions by eHealthMe. Check the latest studies of Thinking abnormal.

On Nov, 05, 2025

17,179 people reported to have side effects when taking Sumatriptan.
Among them, 22 people (0.13%) have Thinking abnormal.

Could Sumatriptan cause Thinking abnormal?

Among these 22 people:

How long have people been on Sumatriptan when they have Thinking abnormal? *

What is the gender of people who have Thinking abnormal when taking Sumatriptan? *

female: 86.36 %
male: 13.64 %

What is the age of people who have Thinking abnormal when taking Sumatriptan? *

What are other drugs people take besides Sumatriptan? *

What are other side effects people have besides Thinking abnormal? *

Pain: 8 people, 36.36%
Confusional State: 8 people, 36.36%
Disturbance In Attention: 7 people, 31.82%
Memory Loss: 7 people, 31.82%
Neck Pain: 6 people, 27.27%
Drowsiness: 6 people, 27.27%
Depression: 6 people, 27.27%
Loss Of Consciousness: 6 people, 27.27%
Dyspnea (difficult or laboured breathing): 6 people, 27.27%
Dry Mouth: 6 people, 27.27%

What are the existing conditions these people have? *

Depression: 8 people, 36.36%
Headache (pain in head): 8 people, 36.36%
Stress And Anxiety: 6 people, 27.27%
Bladder Disorder: 5 people, 22.73%
Sleep Disorder: 4 people, 18.18%
Nausea (feeling of having an urge to vomit): 3 people, 13.64%
Quit Smoking: 2 people, 9.09%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.09%
Urinary Tract Infection: 1 person, 4.55%
Constipation: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sumatriptan:

Sumatriptan (18,157 reports)

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thinking abnormal:

Thinking abnormal (1,147 drugs)

Browse all the conditions that are associated with Thinking abnormal:

Thinking abnormal (1,176 conditions)

Drugs similar to Sumatriptan and Thinking abnormal :

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan) and Sumatriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.